Vivanza Biosciences Ltd

Vivanza Biosciences Ltd

₹ 6.79 4.78%
28 Mar - close price
About

Incorporated in 2016, Vivanza Biosciences
Ltd is in the business of Pharmaceutical Products

Key Points

Business Overview:[1]
Vivanza Biosciences Limited is a specialty pharma company focused on commercializing novel and generic pharmaceuticals, developing oral drug delivery systems, and having expertise in complex oral and topical dose forms including highly potent compounds, modified release products & injections

  • Market Cap 27.2 Cr.
  • Current Price 6.79
  • High / Low 17.9 / 5.70
  • Stock P/E 31.6
  • Book Value 1.21
  • Dividend Yield 0.00 %
  • ROCE 10.9 %
  • ROE 15.8 %
  • Face Value 1.00

Pros

  • Company is expected to give good quarter

Cons

  • Stock is trading at 5.60 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Promoter holding has decreased over last quarter: -2.39%
  • Company has a low return on equity of 9.87% over last 3 years.
  • Company might be capitalizing the interest cost
  • Company has high debtors of 256 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Trading Industry: Trading

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
4.08 2.91 0.23 2.81 1.52 5.85 2.35 1.35 5.86 8.24 9.23 7.62 6.56
3.84 2.99 0.27 2.77 1.49 5.95 2.23 1.38 5.30 8.23 8.64 7.30 6.27
Operating Profit 0.24 -0.08 -0.04 0.04 0.03 -0.10 0.12 -0.03 0.56 0.01 0.59 0.32 0.29
OPM % 5.88% -2.75% -17.39% 1.42% 1.97% -1.71% 5.11% -2.22% 9.56% 0.12% 6.39% 4.20% 4.42%
0.04 0.10 0.48 0.32 0.02 0.00 0.05 0.30 0.01 0.12 0.01 0.05 0.02
Interest 0.11 0.10 0.12 0.10 0.10 0.10 0.10 0.10 0.11 0.11 0.11 0.11 0.10
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Profit before tax 0.17 -0.08 0.32 0.26 -0.05 -0.20 0.07 0.17 0.46 0.02 0.49 0.26 0.21
Tax % 0.00% -62.50% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 600.00% 0.00% 0.00% 0.00%
0.17 -0.13 0.32 0.26 -0.05 -0.20 0.07 0.17 0.46 -0.10 0.49 0.26 0.21
EPS in Rs 0.04 -0.03 0.08 0.06 -0.01 -0.05 0.02 0.04 0.12 -0.02 0.12 0.06 0.05
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
0.00 3.46 6.44 2.66 9.56 9.89 10.39 17.81 31.65
0.06 3.77 5.84 2.68 9.90 9.80 10.45 17.14 30.44
Operating Profit -0.06 -0.31 0.60 -0.02 -0.34 0.09 -0.06 0.67 1.21
OPM % -8.96% 9.32% -0.75% -3.56% 0.91% -0.58% 3.76% 3.82%
0.00 0.04 0.00 0.00 0.57 0.51 0.83 0.48 0.20
Interest 0.00 0.04 0.37 0.42 0.44 0.47 0.43 0.43 0.43
Depreciation 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.00 0.00
Profit before tax -0.06 -0.31 0.23 -0.44 -0.21 0.12 0.33 0.72 0.98
Tax % 0.00% 0.00% 13.04% 0.00% 0.00% 41.67% 0.00% 16.67%
-0.06 -0.31 0.21 -0.44 -0.21 0.08 0.33 0.60 0.86
EPS in Rs -0.32 -0.08 0.05 -0.11 -0.05 0.02 0.08 0.15 0.21
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: 23%
3 Years: 23%
TTM: 105%
Compounded Profit Growth
10 Years: %
5 Years: 23%
3 Years: 69%
TTM: 10%
Stock Price CAGR
10 Years: 16%
5 Years: 28%
3 Years: -20%
1 Year: -64%
Return on Equity
10 Years: %
5 Years: 2%
3 Years: 10%
Last Year: 16%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 0.19 4.00 4.00 4.00 4.00 4.00 4.00 4.00 4.00
Reserves -0.16 -0.47 -0.27 -0.71 -0.92 -0.84 -0.51 0.09 0.85
0.50 0.90 1.32 1.48 0.39 0.36 5.51 8.00 5.26
0.11 2.73 5.10 6.33 8.89 4.93 6.56 10.39 18.53
Total Liabilities 0.64 7.16 10.15 11.10 12.36 8.45 15.56 22.48 28.64
0.00 2.31 2.31 2.31 2.31 2.32 2.32 2.31 2.32
CWIP 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
0.64 4.85 7.84 8.79 10.05 6.13 13.24 20.17 26.32
Total Assets 0.64 7.16 10.15 11.10 12.36 8.45 15.56 22.48 28.64

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
0.00 -2.07 -0.09 0.86 2.98 -3.08 2.47 -0.95
0.00 1.90 0.00 0.00 0.00 -0.02 0.00 0.00
0.00 0.39 -0.55 -0.89 -2.75 2.80 -2.48 1.03
Net Cash Flow 0.00 0.23 -0.64 -0.03 0.22 -0.30 -0.01 0.09

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 266.89 287.35 782.14 249.70 230.66 275.42 255.77
Inventory Days 215.20 150.49 309.32 38.07 25.93 91.82 54.64
Days Payable 304.36 319.46 878.47 319.47 153.98 207.06 211.26
Cash Conversion Cycle 177.72 118.38 212.99 -31.71 102.61 160.18 99.15
Working Capital Days 388.21 281.12 592.78 116.07 117.36 204.81 185.06
ROCE % -10.48% 12.66% -0.41% 5.58% 16.88% 12.14% 10.91%

Shareholding Pattern

Numbers in percentages

20 Recently
Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
47.80% 47.80% 47.80% 47.80% 47.80% 47.80% 47.80% 47.80% 47.80% 47.80% 47.29% 44.90%
52.20% 52.20% 52.20% 52.20% 52.20% 52.20% 52.20% 52.20% 52.20% 52.20% 52.70% 55.10%
No. of Shareholders 4,6174,6134,6194,6414,6434,6364,6624,6744,8724,8675,0395,937

Documents